Worldwide $3+ Trillion Health Insurance Market Size is Expected to Grow at a CAGR of over 4.4% During 2022-2028 | Vantage Market Research WASHINGTON, April 11, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Health Insurance Market finds that the increase in adoption of data analytics is expediting...

Clearside Biomedical Expands Patent Portfolio in the U.S. and Europe ALPHARETTA, Ga., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...

Astellas Submits New Drug Application in Japan of Roxadustat for The Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis TOKYO and SAN FRANCISCO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and FibroGen, Inc. (Nasdaq: FGEN, CEO: Thomas B....

IntelGenx Announces Notice of Grant of European Patent Covering  Rizaport® VersaFilm™ SAINT LAURENT, Quebec, June 19, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that the European Patent Office (“EPO”) has issued a...